4//SEC Filing
Diffusion Pharmaceuticals Inc. 4
Accession 0001437749-17-008974
$CRVOCIK 0001053691operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 5:32 PM ET
Size
5.3 KB
Accession
0001437749-17-008974
Insider Transaction Report
Form 4
Kalergis David G
DirectorChairman and CEO
Transactions
- Award
Stock Option (Right to Buy)
2017-05-10+41,000→ 41,000 totalExercise: $2.95Exp: 2027-05-10→ Common Stock (41,000 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on May 31, 2020.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001053691
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 5:32 PM ET
- Size
- 5.3 KB